Login
$AKBA
$0.47 +$0.02 (5.1%) After hours

$AKBA 8-K/A SEC Filings

Filed On Filing
15 Dec 2021 8-K/A: Departure/Election of Directors or Officers; Compensation

On November 1, 2021, Akebia Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Initial 8-K”) disclosing that on and effective November 1, 2021, the Board of Directors of the Company (the “Board”) increased the Bo...

20 Dec 2018 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

14 Dec 2016 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

22 Sep 2014 8-K/A: Departure/Election of Directors or Officers; Compensation

As previously disclosed in the Current Report on Form 8-K filed by Akebia Therapeutics, Inc. (the “Company”) on July 17, 2014, the Company’s Board of Directors (the “Board”) elected Michael Clayman, M.D. and Maxine Gowen, Ph.D. as direct...

22 Sep 2014 8-K/A: Departure/Election of Directors or Officers; Compensation

As previously disclosed in the Current Report on Form 8-K filed by Akebia Therapeutics, Inc. (the “Company”) on September 15, 2014, the Company’s Board of Directors (the “Board”) elected Ronald C. Renaud, Jr. as a director. Mr. Renaud wa...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support